companies that make glp 1 drugs GLP-1 medications like Wegovy and Ozempic have been miracle for patients seeking to treat obesity and type 2 diabetes. However, their high costs have made them inaccessible for many patients, prompting Asia-Pacific Glucagon-like Peptide-1 (GLP-1) Agonists
Description
Among them, gastrointestinal adverse reactions mainly occurred in the early stage of the first drug use, with mild to moderate degrees (109)

My question: given my MS stability but significant metabolic risk factors (obesity, pre-diabetes, cholesterol, thyroid), do you think a GLP-1 agonist (such as tirzepatide or semaglutide) would be a reasonable option for me

Self-pay option is a very attractive option, Dr

Problem #4: They Are Used as a Crutch to a Healthy Lifestyle Another huge problem is that many people end up using GLP-1 agonists because its the path of least resistance

Superguts prebiotic fibers, including resistant starch and beta-glucan, are formulated to promote GLP-1 activity and help control cravings
